Covid-19 in China - Statistics & Facts

At the beginning of December 2019, China has confirmed that they have been treating the first cases that were identified from patients with severe pneumonia in the hospitals in Wuhan, China. The World Health Organization (WHO) then named the disease caused by the SARS-like virus, COVID-19 which was later on declared as a pandemic on March 11, 2020.

The pandemic has severely affected the world’s entire economy. Presently, a second wave was believed to be reported in Wuhan and the northeastern border province Jilin which is now the new hotspot for COVID-19 in the country. The virus has now infected over five million people so far and has caused more than 330 thousand deaths throughout the world. The experts are still studying about the virus and are looking for a possible vaccine to stop this pandemic. Little is known about this virus, except from the possible incubation of 2 to 14 days with a mortality rate that varies by age, gender and pre-existing health conditions.

Coronavirus originated in animals and is usually not transmissible to humans. It is still not clear how the virus jumped from animals to humans. Since the start of the century, it is believed that coronavirus have jumped to humans which appears to have originated in bats. The Huanan Seafood Wholesale Market in Wuhan has been widely considered as the epicenter of the outbreak. According to the analysis of The Lancet, around half of 99 surveyed patients have history of exposure in the said market.

The Chinese government took an aggressive action at the start of the outbreak to combat the virus, which includes the cancelation of all Chinese New Year celebrations and a strict nationwide lockdown. A 25,000 square meter Huosshenshan Hospital was built in 10 days with a capacity of 1,000 beds to expand the hospital capacity. On April 08, 2020, China lifted the ten-week lockdown on Wuhan after no new deaths was reported for the first time. Since then, daily life was returning slowly and welcoming the new normal in the country. Recently, on April 17, 2020 health authorities in Wuhan revised its death toll, adding up 50 percent more fatalities.

Some of the well-known and big companies have shut down their operations due to this virus that have severely impacted global business and tourism. Travel restrictions were imposed inside and outside of China and on some countries, too. Due to its impact on China’s trade and effects on various industries across the world, the coronavirus is expected to result in a further slow down to the Chinese GDP growth in 2020.


In 2019, the growth in real gross domestic product (GDP) in China amounted to about 6.1 percent. Forecasts by the IMF expect a decline in GDP growth to 1.1 percent in 2020 due to the coronavirus COVID-19 pandemic, and GDP growth of 9.2 percent in 2021.


The current gross domestic product is an important indicator of the economic strength of a country. It refers to the total market value of all goods and services that are produced within a country per year. When analyzing year-on-year changes, the current GDP is adjusted for inflation, thus making it constant. Real GDP growth is regarded as a key indicator for economic growth as it incorporates constant GDP figures. As of 2019, China was among the leading countries with the largest gross domestic product worldwide, second only to the United States which had a GDP volume of almost 21.5 trillion U.S. dollars. The Chinese GDP has shown remarkable growth over the past years. Upon closer examination of the distribution of GDP across economic sectors, a gradual shift from an economy heavily based on industrial production towards an economy focused on services becomes visible, with the service industry outpacing the manufacturing sector in terms of GDP contribution.



Another important indicator for economic assessment is the balance of trade, which measures the relationship between imports and exports of a nation. As an economy heavily reliant on manufacturing and industrial production, China has reached a trade surplus over the last decade, with a total trade balance of around 351 billion U.S. dollars in 2018.



Sputnik-V rollout in Delhi, Postponed Once Again!

Treatment Using Genetic Engineering and Light-Activated Therapy has Helped a Blind Man Regain Partial Sight in One Eye

Sanofi S.A. has Agreed to a Pensions Package of Approximately £770 million ($1.1 billion)

French CDMO Yposkesi to Build a Second Commercial Cell and Gene Therapy Plant

Unusable Vaccine Doses at Baltimore Plant Investigated by FDA

Danish government needs to reevaluate dropped antibodies

WHO currently utilizing Greek letters in order for Covid variation names

GP Clinics is now ready to accept COVID-19 Vaccinations for ages over 50

EU Signed a Contract with Pfizer for Almost 1.8 Billion Doses of the Coronavirus Vaccine

Pfizer has gauge $26 billion in Covid-19 antibody deals this year

Hospira, Inc Under Investigation After Reported Mislabeling

Global Access to COVID-19 Vaccines

Moderna Is Testing a New Version of Its COVID-19 Vaccine That Wouldn’t Require Ultra-Cold Storage

No Logical Proof COVID-19 Vaccine Affects Menstruation or Fertility

Full Steam Ahead on Johnson & Johnson and AstraZeneca Vaccines

India Established a Record for Daily Infections Worldwide

Vaccines to Detainees at Guantanamo Bay are now being Offered by the U.S.

Israel's Quick and Effective Vaccine Rollout

J&J Pause a Mere Bump in the U.S. Antibody Rollout?

Stoppage in the Utilization of Johnson and Johnson's Covid-19 Vaccine

Supply Constraints Ease in U.S. Vaccine Rollout

Israel's Vaccine Rollout Curbs Covid-19 Spread

Effects of England's salt reduction Program

The COVID-19 Vaccination Race in Asia

UK and the EU are as yet entangled in an unpleasant disagreement about a deficiency of antibodies across Europe

Progress of COVAX Deliveries

Non-AstraZeneca option for under 30s; E.U. tracks down a 'potential connect' to rare clots

Emergent BioSolutions Threw Out Millions of Doses of Covid-19 Vaccines

Kidney Transplants on the Rise

Vaccine Passports

Coronavirus Briefing: U.S. Economy Bounces Back

India Recorded its Highest Tally of New Coronavirus Infections

Moderna dishes out for CEO security as its COVID-19 immunization gets the spotlight

How soon until the Pfizer antibody is ready for aged 12-15 years old?

Netherlands the Latest Country to Prohibit the Use of AstraZeneca Shot

Antibody injections could turn out to be more reasonable with the new production method

NHS study finds that CT scan gets 70% of Lung Cancer at the Beginning Phase

How to Apply DQ/IQ/OQ/PQ in New Framework

Design of an Efficient Stability Programme -Bracketing and Matrixing

QP Declaration

Negotiations on Cost and Availability of New Pharmaceuticals

5 Health Care Stocks to Bet on as Coronavirus Woes Linger

Coronavirus Impact on the Tourism Industry Worldwide

Cold chain distribution; route qualification approaches

The v model in validation

GAMP V computer system validation